Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Aug 31;67(6):962-964.
doi: 10.1093/cid/ciy321.

Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis

Donn J Colby  1 , Eugene Kroon  1 , Carlo Sacdalan  1 , Monica Gandhi  2 , Robert M Grant  2 , Praphan Phanuphak  1 , Jintanat Ananworanich  3   4 , Merlin L Robb  3   4 , Nittaya Phanuphak  1
Affiliations
Case Reports

Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis

Donn J Colby et al. Clin Infect Dis. .

Abstract

We report a case indicating that acquisition of multidrug-resistant human immunodeficiency (HIV) virus type 1 during preexposure prophylaxis with combination tenofovir disoproxil fumarate and emtricitabine or evolution of resistance after HIV seroconversion remains a risk.

PubMed Disclaimer

References

    1. Liu AY, Yang Q, Huang Y, et al. . Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP). PLOS One 2014; 9:e83736. - PMC - PubMed
    1. Hendrix CW, Andrade A, Bumpus NN, et al. . Dose frequency ranging pharmacokinetic study of tenofovir-emtricitabine after directly observed dosing in healthy volunteers to establish adherence benchmarks (HPTN 066). AIDS Res Hum Retroviruses 2016; 32:32–43. - PMC - PubMed
    1. Knox DC, Anderson PL, Harrigan PR, Tan DH. Multidrug-resistant HIV-1 infection despite preexposure prophylaxis. N Engl J Med 2017; 376:501–2. - PubMed
    1. Markowitz M, Grossman H, Anderson PL, et al. . Newly acquired infection with multidrug-resistant HIV-1 in a patient adherent to preexposure prophylaxis. J Acquir Immune Defic Syndr 2017; 76:e104–6. - PMC - PubMed
    1. Grant RM, Lama JR, Anderson PL, et al. . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363:2587–99. - PMC - PubMed

Publication types